Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma

NCT00026910 · clinicaltrials.gov ↗
COMPLETED
Status
200
Enrollment
NIH
Sponsor class

Conditions

Sponsor

National Cancer Institute (NCI)